Skip to main content
Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. — Investor Relations & Filings

Ticker · QLGN ISIN · US74754R1032 US Professional, scientific and technical activities
Filings indexed 618 across all filing types
Latest filing 2025-11-21 Regulatory Filings
Country US United States of America
Listing US QLGN

About Qualigen Therapeutics, Inc.

https://qlgntx.com/

Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2025-11-21 English
8-K
Regulatory Filings
2025-11-21 English
8-K
Regulatory Filings
2025-11-20 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-19 English
8-K
Regulatory Filings
2025-11-17 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.